[1] Fang S, Liang J, Qian T, et al. Anatomic location of tumor predicts the accuracy of motor function localization in diffuse lower-grade gliomas involving the hand knob area[J]. AJNR Am J Neuroradiol, 2017,38(10):1990-1997. [2] Fang S, Bai H X, Fan X, et al. A novel sequence:ZOOMit-blood oxygen level-dependent for motor-cortex localization[J]. Neurosurgery, 2020,86(2):E124-E132. [3] Fang S, Li Y, Wang Y, Zhang Z, et al. Awake craniotomy for gliomas involving motor-related areas:classification and function recovery[J]. J Neurooncol, 2020,148(2):317-325. [4] Wang Y, Qian T, You G, et al. Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping[J]. Neuro Oncol, 2015,17(2):282-288. [5] Fan X, Li Y, Shan X, et al. Seizures at presentation are correlated with better survival outcomes in adult diffuse glioma:a systematic review and meta-analysis[J]. Seizure,2018,59:16-23. [6] Fan X, Wang Y Y, Zhang C B, et al. Expression of RINT1 predicts seizure occurrence and outcomes in patients with low-grade gliomas[J]. J Cancer Res Clin Oncol, 2015,141(4):729-734. [7] You G, Yan W, Zhang W, et al. Significance of miR-196b in tumor-related epilepsy of patients with gliomas[J]. PloS One 2012,7(9):e46218. [8] Pallud J, Audureau E, Blonski M, et al. Epileptic seizures in diffuse low-grade gliomas in adults[J]. Brain, 2014,137(Pt 2):449-462. [9] Huberfeld G, Vecht C J. Seizures and gliomas-towards a single therapeutic approach[J]. Nat Rev Neurol, 2016,12(4):204-216. [10] Bao Z S, Chen H M, Yang M Y, et al. RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas[J]. Genome Res, 2014,24(11):1765-1773. [11] Hu H, Mu Q, Bao Z, et al. Mutational landscape of secondary glioblastoma guides MET-Targeted trial in brain tumor[J]. Cell, 2018,175(6):1665-1678. e118. [12] Yan W, Zhang W, You G, et al. Molecular classification of gliomas based on whole genome gene expression:a systematic report of 225 samples from the Chinese Glioma Cooperative Group[J]. Neuro Oncol, 2012,14(12):1432-1440. [13] Jiang T, Mao Y, Ma W, et al. CGCG clinical practice guidelines for the management of adult diffuse gliomas[J]. Cancer Lett, 2016,375(2):263-273. [14] Zhang T, Wang Y, Fan X, et al. Anatomical localization of p53 mutated tumors:A radiographic study of human glioblastomas[J]. J Neurol Sci, 2014,346(1-2):94-98. [15] Fan X, Wang Y, Wang K, et al. Anatomical specificity of vascular endothelial growth factor expression in glioblastomas:a voxel-based mapping analysis[J]. Neuroradiology, 2016,58(1):69-75. [16] Wang Y, Fan X, Zhang C, et al. Anatomical specificity of O6-methylguanine DNA methyltransferase protein expression in glioblastomas[J]. J Neurooncol, 2014,120(2):331-337. [17] Wang Y, Zhang T, Li S, et al. Anatomical localization of isocitrate dehydrogenase 1 mutation:a voxel-based radiographic study of 146 low-grade gliomas[J]. Eur J Neurol, 2015,22(2):348-354. [18] Wang Y Y, Zhang T, Li S W, et al. Mapping p53 mutations in low-grade glioma:a voxel-based neuroimaging analysis[J]. AJNR American J Neuroradiol, 2015,36(1):70-76. [19] Ding X, Wang Z, Chen D, et al. The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma:a multicenter retrospective study[J]. J Neurooncol, 2018,140(3):591-603. [20] Liu X, Li Y, Li S, et al. IDH mutation-specific radiomic signature in lower-grade gliomas[J]. Aging (Albany NY), 2019,11(2):673-696. [21] Li Y, Liu X, Qian Z, et al. Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature[J]. Eur Radiol, 2018,28(7):2960-2968. [22] Li Y, Qian Z, Xu K, et al. MRI features predict p53 status in lower-grade gliomas via a machine-learning approach[J]. NeuroImage Clin, 2018,17:306-311. [23] Li Y, Qian Z, Xu K, et al. Radiomic features predict Ki-67 expression level and survival in lower grade gliomas[J]. J Neurooncol, 2017,135(2):317-324. [24] Li Y, Liang Y, Sun Z, et al. Radiogenomic analysis of PTEN mutation in glioblastoma using preoperative multi-parametric magnetic resonance imaging[J]. Neuroradiology, 2019,61(11):1229-1237. [25] Sun Z, Li Y, Wang Y, et al. Radiogenomic analysis of vascular endothelial growth factor in patients with diffuse gliomas[J]. Cancer Imaging, 2019,19(1):68. [26] Li Y, Liu X, Xu K, et al. MRI features can predict EGFR expression in lower grade gliomas:a voxel-based radiomic analysis[J]. Eur Radiol, 2018,28(1):356-362. |